Report - Updates in AL Amyloidosis: The Moffitt Experience• Cardiac response 17% ; Renal response 25% • Lower response rate in stage III cardiac patients [NT-ProBNP> 8500] (42%, ≥ VGPR

Please pass captcha verification before submit form